1. Home
  2. ACIU vs NEGG Comparison

ACIU vs NEGG Comparison

Compare ACIU & NEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • NEGG
  • Stock Information
  • Founded
  • ACIU 2003
  • NEGG 2001
  • Country
  • ACIU Switzerland
  • NEGG United States
  • Employees
  • ACIU N/A
  • NEGG N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • NEGG Other Specialty Stores
  • Sector
  • ACIU Health Care
  • NEGG Consumer Discretionary
  • Exchange
  • ACIU Nasdaq
  • NEGG Nasdaq
  • Market Cap
  • ACIU 332.4M
  • NEGG 180.8M
  • IPO Year
  • ACIU 2016
  • NEGG 2010
  • Fundamental
  • Price
  • ACIU $2.71
  • NEGG $0.46
  • Analyst Decision
  • ACIU Strong Buy
  • NEGG
  • Analyst Count
  • ACIU 2
  • NEGG 0
  • Target Price
  • ACIU $12.00
  • NEGG N/A
  • AVG Volume (30 Days)
  • ACIU 130.0K
  • NEGG 787.1K
  • Earning Date
  • ACIU 11-05-2024
  • NEGG 01-07-2025
  • Dividend Yield
  • ACIU N/A
  • NEGG N/A
  • EPS Growth
  • ACIU N/A
  • NEGG N/A
  • EPS
  • ACIU N/A
  • NEGG N/A
  • Revenue
  • ACIU $48,505,404.00
  • NEGG $1,391,833,000.00
  • Revenue This Year
  • ACIU $85.33
  • NEGG $6.01
  • Revenue Next Year
  • ACIU $80.69
  • NEGG N/A
  • P/E Ratio
  • ACIU N/A
  • NEGG N/A
  • Revenue Growth
  • ACIU 4097200.00
  • NEGG N/A
  • 52 Week Low
  • ACIU $2.25
  • NEGG $0.43
  • 52 Week High
  • ACIU $5.14
  • NEGG $1.45
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 29.89
  • NEGG 32.45
  • Support Level
  • ACIU $2.62
  • NEGG $0.43
  • Resistance Level
  • ACIU $3.07
  • NEGG $0.66
  • Average True Range (ATR)
  • ACIU 0.15
  • NEGG 0.05
  • MACD
  • ACIU -0.04
  • NEGG -0.01
  • Stochastic Oscillator
  • ACIU 17.24
  • NEGG 13.43

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About NEGG Newegg Commerce Inc.

Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.

Share on Social Networks: